Sign in Subscribe

U.S. FDA Approves Jazz's Combination Therapy for Lung Cancer

The FDA approved the Zepzelca/Tecentriq drug combo as a maintenance treatment for advanced small cell lung cancer.

U.S. FDA Approves Jazz's Combination Therapy for Lung Cancer
Pulmonary Pathology, CC BY-SA 2.0, via Wikimedia Commons
Already have an account? Sign in.